High-Flow Nasal Cannula in a Parkinson's Disease Patient Undergoing Deep Brain Stimulation in the Awake State

Abstract

The administration of deep brain stimulation (DBS) in patients with Parkinson's disease is commonly carried out with the patient in an awake state with conscious sedation. However, maintaining the airway and preventing desaturation can be challenging during the procedure. High-flow nasal cannula (HFNC) has been deemed to be a safe option for providing respiratory support in such patients, affording multiple benefits. We report the case of a 48-year-old male patient with Parkinson's disease who underwent DBS, during which HFNC was employed for respiratory support. The patient tolerated the HFNC well, and the procedure was conducted without any complications related to respiratory function.

Keywords

Parkinson's - deep brain stimulation - high-flow nasal cannula - conscious sedation - awake state

Publikationsverlauf

Artikel online veröffentlicht:
04. Dezember 2024

• References

• 1 Chakrabarti R, Ghazanwy M, Tewari A. Anesthetic challenges for deep brain stimulation: a systematic approach. N Am J Med Sci 2014; Aug; 06 (08) 359-369
• 2 Roca O, Li J, Mauri T. High-flow nasal cannula: evolving practices and novel clinical and physiological insights. Intensive Care Med 2024; 50 (05) 758-761
• 3 Gook J, Kwon J-H, Kim K, Choi JW, Chung IS, Lee J. Awake craniotomy using a high-flow nasal cannula with oxygen reserve index monitoring: a report of two cases. Anesth Pain Med (Seoul) 2021; 16 (04) 338-343
• 4 Nishimura M. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care 2016; 61 (04) 529-541
• 5 Delorme M, Bouchard P-A, Simon M, Simard S, Lellouche F. Effects of high-flow nasal cannula on the work of breathing in patients recovering from acute respiratory failure. Crit Care Med 2017; 45 (12) 1981-1988
• 6 Karim HMR, Esquinas AM, O'Brien B. Flow effects of high-flow nasal oxygenation: comment. Anesthesiology 2023; 138 (05) 566-567
• 7 Parke R, McGuinness S, Eccleston M. Nasal high-flow therapy delivers low level positive airway pressure. Br J Anaesth 2009; 103 (06) 886-890
• 8 Rattanajiajaroen P, Kongpolprom N. Effects of high flow nasal cannula on the coordination between swallowing and breathing in postextubation patients, a randomized crossover study. Crit Care 2021; 25 (01) 365
• 9 Lee CZ, Poon CCM. An update of neuroanesthesia for intraoperative brain mapping craniotomy. Neurosurgery 2022; 90 (01) 1-6
• 10 Yi P, Li Q, Yang Z, Cao L, Hu X, Gu H. High-flow nasal cannula improves clinical efficacy of airway management in patients undergoing awake craniotomy. BMC Anesthesiol 2020; 20 (01) 156
• 11 Kumari N, Kumari B, Kumar S, Arun N, Kumari R. Effectiveness of high flow nasal cannula (HFNC) versus bilevel positive airway pressure (BiPAP) in preventing tracheal reintubation in patients with high risk of extubation failure in intensive care unit: a randomised comparative trial. Indian J Anaesth 2024; 68 (03) 246-253
• 12 Paquin-Lanthier G, Subramaniam S, Leong KW. et al. Risk factors and characteristics of intraoperative seizures during awake craniotomy: a retrospective cohort study of 562 consecutive patients with a space-occupying brain lesion. J Neurosurg Anesthesiol 2023; 35 (02) 194-200
• 13 Vaithialingam B, Sriganesh K. Trans-nasal humidified rapid insufflation ventilatory exchange (THRIVE) in neuroanesthesia practice: a review. J Anaesthesiol Clin Pharmacol 2023; 39 (04) 521-527
• 14 Sethuraman M, Bidkar PU, Mariappan R, Deopujari RC, Vanamoorthy P, Massand M. Recent advancements in the practice of neuroanaesthesia and neurocritical care: an update. Indian J Anaesth 2023; 67 (01) 85-90